Cerebrospinal fluid levels of tau, phophorylated-tau, and amyloid beta 1-42 in subjects with MCI

被引：0
|
作者：
Andreasen, N [1 ]
Verbeek, M [1 ]
Scheltens, P [1 ]
Wahlund, LO [1 ]
Zetterberg, H [1 ]
Blennow, K [1 ]
Verhey, F [1 ]
Visser, PJ [1 ]
机构：
[1] Karolinska Inst, Dept Geriatr Med, S-10401 Stockholm, Sweden
来源：
INTERNATIONAL PSYCHOGERIATRICS | 2005年 / 17卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [1] Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
    Skillback, Tobias
    Farahmand, Bahman Y.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    BRAIN, 2015, 138 : 2716 - 2731
  • [2] Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury
    Blennow, K
    Nellgård, B
    NEUROLOGY, 2004, 62 (01) : 159 - 159
  • [3] Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury
    Franz, G
    Beer, R
    Kampfl, A
    Engelhardt, K
    Schmutzhard, M
    Ulmer, H
    Deisenhammer, F
    NEUROLOGY, 2003, 60 (09) : 1457 - 1461
  • [4] Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
    Mulder, Cees
    Verwey, Nicolaas A.
    van der Flier, Wiesje M.
    Bouwman, Femke H.
    Kok, Astrid
    van Elk, Evert J.
    Scheltens, Philip
    Blankenstein, Marinus A.
    CLINICAL CHEMISTRY, 2010, 56 (02) : 248 - 253
  • [5] CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
    Formichi, P.
    Parnetti, L.
    Radi, E.
    Cevenini, G.
    Dotti, M. T.
    Federico, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (11) : 1252 - 1255
  • [6] Cerebrospinal fluid tau and beta-amyloid(1-42) proteins identify Alzheimer's disease in subjects with mild cognitive impairment
    Riemenschneider, M
    Diehl, J
    Lautenschlager, N
    Wagenpfeil, S
    Drzezga, A
    Förstl, H
    Kurz, A
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S381 - S382
  • [7] Vitreous fluid levels of β-amyloid(1-42) and tau in patients with retinal diseases
    Yoneda, S
    Hara, H
    Hirata, A
    Fukushima, M
    Inomata, Y
    Tanihara, H
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2005, 49 (02) : 106 - 108
  • [8] Amyloid beta 1-42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer's disease
    Shea, Yat Fung
    Chu, Leung-wing
    Mok, Ming-yee Maggie
    Lam, Man-Fai
    JOURNAL OF NEPHROLOGY, 2014, 27 (02) : 217 - 220
  • [9] Improved diagnostic discrimination of patients with vascular dementia using tau and β-amyloid(1-42) levels in cerebrospinal fluid
    Mielke, R
    Strohmeier, M
    Nekic, M
    Bamborschke, S
    Kessler, J
    Behrendt, J
    Heiss, WD
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 459 - 459
  • [10] Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
    Marksteiner, Josef
    Hinterhuber, Hartmann
    Humpel, Christian
    DRUGS OF TODAY, 2007, 43 (06) : 423 - 431
12345